Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 10/20 | 0.58 |
| ▸ | AMY1A | P0DUB6 | 10/20 | 0.58 |
| ▸ | GAA | P10253 | 10/20 | 0.58 |
| ▸ | SI | P14410 | 10/20 | 0.58 |
| ▸ | MGAM2 | Q2M2H8 | 10/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.58 |
| ▸ | F12 | P00748 | 5/20 | 0.56 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.56 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15761538 | 0.83 | FAAH (0.60) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL427058 | 0.80 | GAA (0.64) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL706083 | 0.80 | MGAM (0.68) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL4250719 | 0.80 | GAA (0.68) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL1756653 | 0.78 | DGAT1 (0.69) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL170673 | 0.78 | GAA (0.71) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL6402628 | 0.77 | GAA (0.55) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL17994057 | 0.77 | GAA (0.55) | MGAMAMY1AGAASIMGAM2 | |
| Ammonia Solution, Strong SCHEMBL3505685 | 0.77 | GAA (0.69) | MGAMAMY1AGAASIMGAM2 | |
| SCHEMBL10621117 | 0.77 | GAA (0.64) | MGAMAMY1AGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220152211-A1 | HYBRID CURCUMIN CONJUGATES AND METHODS OF USE THEREOF | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2022-05-19 | — | — | US | disclosed |
| EP-3467930-B1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2020-05-13 | — | — | EP | disclosed |
| EP-3467930-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-04-10 | — | — | EP | disclosed |
| EP-3279997-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | Asahi Kasei Kabushiki Kaisha (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220152211-A1 | HYBRID CURCUMIN CONJUGATES AND METHODS OF USE THEREOF | DHFR, CD44, MTHFD2 | MGAM 3732/4885AMY1A 4845/4885GAA 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.